Repurposed Drug May Extend Survival in Aggressive Ovarian Cancer
A clinical trial reveals that relacorilant, a drug used for Cushing's syndrome, could improve outcomes for patients with platinum-resistant ovarian cancer, offering new hope in treatment.


